[第五届匈牙利乳腺癌共识会议 - 放射治疗指南]
Viktor Smanykó1, Zsuzsanna Kahán2, Gabriella Gábor3
1Sugárterápiás Központ, Országos Onkológiai Intézet, Budapest, Hungary. polgar.c@outlook.com.
Magyar onkologia
|September 26, 2025
概括
更新的乳腺癌放射治疗指南建议在乳腺保护性手术后用于 in situ 导管癌和早期侵袭性癌症. 低分量全乳房照射是一种传统治疗的替代方案.
科学领域:
- 在瘤学瘤学.
- 放射疗法是一种放射治疗.
- 乳腺癌治疗方法 乳腺癌治疗方法
背景情况:
- 第四届匈牙利乳腺癌共识会议根据新的证据修订了放射治疗指南.
- 乳腺保护手术 (BCS) 后的放射治疗对于减少在位管道癌 (DCIS) 和早期侵袭性乳腺癌的局部复发 (LR) 是至关重要的.
研究的目的:
- 更新和介绍乳腺癌管理的放射治疗指南.
- 将新的科学证据纳入已建立的治疗方案.
主要方法:
- 专家小组审查和修订现有的放射治疗指南.
- 包括对低分数和加速部分乳房照射技术的数据.
- 在特定的患者群体中考虑激素治疗作为放射治疗的替代方案.
主要成果:
- 在BCS之后的放射治疗在DCIS中将LR降低了50-60%.
- 低分离或超低分离全乳房照射 (WBI) 是传统WBI的验证替代方案.
- 乳腺切除术后的放射治疗改善了结节阳性患者的生存率.
- 轴心放射疗法可以代替轴心剖析在选择的哨兵淋巴结阳性病例.
- 在新辅助化疗 (NAC) 和BCS后,WBI是强制性的;在特定的晚期和节点状态下,在NAC和乳腺切除后建议RT.
结论:
- 更新的指导方针强调了放射治疗在各种乳腺癌情景中的作用,包括BCS后,乳房切除后和新辅助化疗后.
- 低分化WBI和选择性关RT是已知的治疗选择.
- 荷尔蒙疗法可以被视为RT的替代品,在选择的老年患者早期,荷尔蒙受体阳性疾病.
相关概念视频
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K